27.48
price up icon7.74%   1.975
after-market Handel nachbörslich: 27.48
loading
Schlusskurs vom Vortag:
$25.50
Offen:
$24.88
24-Stunden-Volumen:
1.15M
Relative Volume:
3.91
Marktkapitalisierung:
$1.03B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+33.59%
1M Leistung:
+78.44%
6M Leistung:
+237.59%
1J Leistung:
-0.94%
1-Tages-Spanne:
Value
$24.88
$29.20
1-Wochen-Bereich:
Value
$20.25
$29.20
52-Wochen-Spanne:
Value
$5.485
$31.13

Oruka Therapeutics Inc Stock (ORKA) Company Profile

Name
Firmenname
Oruka Therapeutics Inc
Name
Telefon
650-606-7910
Name
Adresse
855 OAK GROVE AVE., MENLO PARK
Name
Mitarbeiter
28
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
ORKA's Discussions on Twitter

Vergleichen Sie ORKA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ORKA
Oruka Therapeutics Inc
27.48 1.18B 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-22 Eingeleitet BTIG Research Buy
2025-02-04 Eingeleitet Wolfe Research Outperform
2024-10-11 Eingeleitet Stifel Buy
2024-10-07 Eingeleitet H.C. Wainwright Buy
2024-09-17 Eingeleitet Leerink Partners Outperform
2024-09-16 Eingeleitet TD Cowen Buy
2024-09-13 Eingeleitet Jefferies Buy
2018-02-27 Eingeleitet Ascendiant Capital Markets Buy
2013-10-09 Eingeleitet Dawson James Buy
Alle ansehen

Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten

pulisher
06:20 AM

Will Oruka Therapeutics Inc. stock outperform growth indexesDip Buying & Free Weekly Watchlist of Top Performers - newser.com

06:20 AM
pulisher
05:30 AM

Will breakout in Oruka Therapeutics Inc. lead to full recovery2025 Short Interest & Long-Term Growth Portfolio Plans - newser.com

05:30 AM
pulisher
12:20 PM

What high frequency data says about Oruka Therapeutics Inc.July 2025 Analyst Calls & Daily Technical Forecast Reports - newser.com

12:20 PM
pulisher
Oct 13, 2025

Will Oruka Therapeutics Inc. stock go up soon2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Barclays Initiates Oruka Therapeutics at Overweight With $48 Price Target - MarketScreener

Oct 13, 2025
pulisher
Oct 13, 2025

Why Oruka Therapeutics Inc. stock attracts global investorsWeekly Trend Recap & Capital Efficient Trade Techniques - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

ORKA: Barclays Initiates Coverage with Overweight Rating | ORKA Stock News - GuruFocus

Oct 13, 2025
pulisher
Oct 13, 2025

Is Oruka Therapeutics Inc. stock supported by strong cash flows2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Is Oruka Therapeutics’ (ORKA) Fundraising Spree a Sign of Strategic Flexibility or Underlying Caution? - Sahm

Oct 12, 2025
pulisher
Oct 12, 2025

Automated trading signals detected on Oruka Therapeutics Inc.Options Play & Safe Capital Investment Plans - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Oruka Therapeutics (NASDAQ:ORKA) Trading Up 7.5%Should You Buy? - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Oruka Therapeutics (ORKA) Is Up 33.2% After Announcing $1.25B Shelf Registration and $200M Offering - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Oruka Therapeutics (NASDAQ:ORKA) - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Exploring a Promising 66.83% Potential Upside - DirectorsTalk Interviews

Oct 10, 2025
pulisher
Oct 10, 2025

How Oruka Therapeutics Inc. (HQ1) stock reacts to monetary easingBull Run & Weekly Top Gainers Trade List - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Why retail traders accumulate Oruka Therapeutics Inc. (HQ1) stockMarket Risk Summary & Daily Chart Pattern Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How Oruka Therapeutics Inc. stock performs in stagflationLong Setup & Consistent Income Trade Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can a trend reversal in Oruka Therapeutics Inc. lead to recoveryWeekly Stock Analysis & Community Consensus Picks - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

What drives Oruka Therapeutics Inc stock priceMarket Entry Points & Budget Investment Success - earlytimes.in

Oct 08, 2025
pulisher
Oct 05, 2025

Constellation Brands, Aehr Test Systems And 3 Stocks To Watch Heading Into Monday - Benzinga

Oct 05, 2025
pulisher
Oct 05, 2025

How reliable is Oruka Therapeutics Inc. (HQ1) stock dividend growthSwing Trade & Advanced Technical Analysis Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Should you wait for a breakout in Oruka Therapeutics Inc.Take Profit & Capital Efficiency Focused Ideas - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Oruka Therapeutics Inc Stock Analysis and ForecastValue Stock Picks & Free Real-Time Trading Alerts Every Day - earlytimes.in

Oct 04, 2025
pulisher
Oct 03, 2025

Oruka Therapeutics files to sell 39.43M shares of common stock for holders - MSN

Oct 03, 2025
pulisher
Oct 03, 2025

Oruka Therapeutics files for mixed shelf of upto $500 millionSEC filing - MarketScreener

Oct 03, 2025
pulisher
Oct 03, 2025

Is Oruka Therapeutics Inc. forming a bottoming baseJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Custom strategy builders for tracking Oruka Therapeutics Inc.2025 Analyst Calls & Daily Technical Forecast Reports - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

What drives Oruka Therapeutics Inc HQ1 stock priceDividend Stability Analysis & Budget Friendly Growth - earlytimes.in

Oct 01, 2025
pulisher
Sep 30, 2025

BTIG Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $56 - 富途牛牛

Sep 30, 2025
pulisher
Sep 29, 2025

MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades - Stocktwits

Sep 29, 2025
pulisher
Sep 29, 2025

Oruka Therapeutics (NASDAQ:ORKA) Shares Gap UpWhat's Next? - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Oruka Therapeutics (NASDAQ:ORKA) Receives Buy Rating from BTIG Research - MarketBeat

Sep 29, 2025

Finanzdaten der Oruka Therapeutics Inc-Aktie (ORKA)

Es liegen keine Finanzdaten für Oruka Therapeutics Inc (ORKA) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Oruka Therapeutics Inc-Aktie (ORKA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Venrock Healthcare Capital Par
10% Owner
Feb 13 '25
Buy
11.63
14,950
173,868
4,059,634
Venrock Healthcare Capital Par
10% Owner
Feb 12 '25
Buy
11.86
8,971
106,396
4,044,684
Venrock Healthcare Capital Par
10% Owner
Feb 11 '25
Buy
10.95
9,593
105,043
4,035,713
Venrock Healthcare Capital Par
10% Owner
Feb 10 '25
Buy
10.90
574
6,257
4,026,120
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):